Stay updated with breaking news from Nasdaq Tlis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Talis Biomedical Co. (NASDAQ:TLIS – Get Free Report) saw a significant increase in short interest in October. As of October 31st, there was short interest totalling 17,100 shares, an increase of 19.6% from the October 15th total of 14,300 shares. Currently, 1.0% of the company’s stock are short sold. Based on an average trading volume […]
Talis Biomedical Co. (NASDAQ:TLIS – Get Free Report) saw a significant decline in short interest in September. As of September 30th, there was short interest totalling 11,500 shares, a decline of 25.8% from the September 15th total of 15,500 shares. Approximately 0.7% of the company’s stock are short sold. Based on an average trading volume […]
Talis Biomedical (NASDAQ:TLIS – Get Free Report) will be releasing its earnings data on Monday, July 31st. Talis Biomedical (NASDAQ:TLIS – Get Free Report) last issued its quarterly earnings data on Thursday, May 11th. The company reported ($9.90) earnings per share for the quarter, topping the consensus estimate of ($11.10) by $1.20. Talis Biomedical had […]
-logo.png?v=20221121151525&w=240&h=240&zc=2){kind=logo}
Talis Biomedical (NASDAQ:TLIS – Get Rating) and Olink Holding AB (publ) (NASDAQ:OLK – Get Rating) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, valuation, profitability, analyst recommendations and risk. Insider & Institutional Ownership 47.1% of Talis Biomedical […]
Talis Biomedical Co. (NASDAQ:TLIS – Get Rating) was the recipient of a large growth in short interest during the month of April. As of April 30th, there was short interest totalling 332,400 shares, a growth of 21.4% from the April 15th total of 273,900 shares. Based on an average trading volume of 85,900 shares, the […]